Latest news
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 16:51:52 GMTOutcomes in Early-Stage Triple-Negative Breast Cancer With Dose-Dense Doxorubicin and Cyclophosphamide as Part of Pembrolizumab-Based Regimens - Journal of Hematology Oncology PharmacyJournal of Hematology Oncology Pharmacy · Fri, 07 Aug 2026 16:18:45 GMTWhat To Know About the Prognosis for Triple-Negative Breast Cancer—and Your Risk of It Returning - Health.comHealth.com · Fri, 07 Aug 2026 15:46:34 GMTHow to Ask for Help if You Have HR+/HER2- Metastatic Breast Cancer - Everyday HealthEveryday Health · Fri, 07 Aug 2026 15:28:29 GMTHR-Positive Breast Cancer: ctDNA-Guided De-escalation and Clinical Uncertainty - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 12:25:58 GMTConstitutive androgen receptor activity sustains DNA replication programs in triple-negative breast cancer - NatureNature · Fri, 07 Aug 2026 02:02:11 GMT6 Risk Factors That May Increase Your Risk of Triple-Negative Breast Cancer - Health.comHealth.com · Thu, 06 Aug 2026 20:46:51 GMTPreclinical study shows technology could slow aggressive breast cancer - Spectrum NewsSpectrum News · Thu, 06 Aug 2026 15:20:00 GMT